Litcius/Paper detail

Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis

William R. Treem, Melissa Palmer, Isabelle Lonjon‐Domanec, Daniel Seekins, Lara Dimick‐Santos, Mark Avigan, John Marcinak, Ajit Dash, Arie Regev, Eric S. Maller, Meenal Patwardhan, James H. Lewis, Don C. Rockey, Adrian M. Di Bisceglie, James W. Freston, Raúl J. Andrade, Naga Chalasani

2020Drug Safety41 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCirrhosisClinical trialLiver diseaseViral hepatitisPopulationInternal medicineIntensive care medicineChronic liver diseaseHepatitisNonalcoholic fatty liver diseaseDiseaseFatty liverEnvironmental healthLiver Disease Diagnosis and TreatmentDrug-Induced Hepatotoxicity and ProtectionHepatitis C virus research
Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis | Litcius